TY - JOUR
T1 - Use of T cell-based diagnosis of tuberculosis infection to optimize interpretation of tuberculin skin testing for child tuberculosis contacts
AU - Bakir, Mustafa
AU - Dosanjh, Davinder P.S.
AU - Deeks, Jonathan J.
AU - Soysal, Ahmet
AU - Millington, Kerry
AU - Efe, Serpil
AU - Aslan, Yasemin
AU - Polat, Dilek
AU - Kodalli, Nihat
AU - Yagci, Aysegul
AU - Barlan, Isil
AU - Bahceciler, Nerin
AU - Demiralp, Emel E.
AU - Lalvani, Ajit
PY - 2009/2/1
Y1 - 2009/2/1
N2 - Background. Treatment of recent tuberculosis infection in children aged <2 years is essential, because of high risk of progression to disease, but diagnosis is hindered by the inaccuracy of the tuberculin skin test (TST). More-accurate T cell-based tests of infection could enhance diagnosis by optimizing interpretation of the TST results. Methods. A total of 979 child tuberculosis contacts in Istanbul underwent the TST and enzyme-linked immunospot assay. Using enzyme-linked immunospot test results as a reference standard, we assessed the effect of age and bacille Calmette-Guérin (BCG) vaccination on the sensitivity and specificity of the TST, and we computed the optimal TST cutoff points, using receiver operating characteristic curves. Results. With a TST cutoff point of ≥10 mm, the sensitivity of the TST was 66% for children aged <2 years, which was lower than that for older children (P = .006). Specificity was 75% for BCG-vaccinated children, compared with 92% for unvaccinated children (P = .001). Optimal cutoff points improved TST specificity for children with 1 BCG scar, with little loss of sensitivity. Despite the use of optimal cutoff points, TST sensitivity remained <70% for children aged <2 years, specificity remained <87% for BCG-vaccinated children aged ≥2 years, and overall accuracy was low for children with >1 BCG scar. Conclusions. Negative results of the TST cannot exclude tuberculosis infection for child tuberculosis contacts aged <2 years, which supports the use of preventive therapy regardless of the TST results for this age group. In children aged ≥2 years, the accuracy of the TST can be improved by adjustment of cutoff points for BCG-vaccinated children but remains poor for children with >1 BCG scar. This methodology can define optimal TST cutoff points for diagnosis of tuberculosis infection tailored to target populations.
AB - Background. Treatment of recent tuberculosis infection in children aged <2 years is essential, because of high risk of progression to disease, but diagnosis is hindered by the inaccuracy of the tuberculin skin test (TST). More-accurate T cell-based tests of infection could enhance diagnosis by optimizing interpretation of the TST results. Methods. A total of 979 child tuberculosis contacts in Istanbul underwent the TST and enzyme-linked immunospot assay. Using enzyme-linked immunospot test results as a reference standard, we assessed the effect of age and bacille Calmette-Guérin (BCG) vaccination on the sensitivity and specificity of the TST, and we computed the optimal TST cutoff points, using receiver operating characteristic curves. Results. With a TST cutoff point of ≥10 mm, the sensitivity of the TST was 66% for children aged <2 years, which was lower than that for older children (P = .006). Specificity was 75% for BCG-vaccinated children, compared with 92% for unvaccinated children (P = .001). Optimal cutoff points improved TST specificity for children with 1 BCG scar, with little loss of sensitivity. Despite the use of optimal cutoff points, TST sensitivity remained <70% for children aged <2 years, specificity remained <87% for BCG-vaccinated children aged ≥2 years, and overall accuracy was low for children with >1 BCG scar. Conclusions. Negative results of the TST cannot exclude tuberculosis infection for child tuberculosis contacts aged <2 years, which supports the use of preventive therapy regardless of the TST results for this age group. In children aged ≥2 years, the accuracy of the TST can be improved by adjustment of cutoff points for BCG-vaccinated children but remains poor for children with >1 BCG scar. This methodology can define optimal TST cutoff points for diagnosis of tuberculosis infection tailored to target populations.
U2 - 10.1086/595847
DO - 10.1086/595847
M3 - Article
SN - 1058-4838
VL - 48
SP - 302
EP - 312
JO - Clinical Infectious Diseases
JF - Clinical Infectious Diseases
IS - 3
ER -